Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:44 +0200Wed, 20 Mar 2024 15:05:00 +0100Human medicines European public assessment report (EPAR): Zeffix, lamivudine, Date of authorisation: 29/07/1999, Revision: 29, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zeffixHuman medicines European public assessment report (EPAR): Zeffix, lamivudine, Date of authorisation: 29/07/1999, Revision: 29, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zeffixWed, 20 Mar 2024 15:05:00 +0100Human medicineZeffix : EPAR - Steps taken after authorisation when a cutoff date has been usedhttps://www.ema.europa.eu/system/files/documents/steps-after-cutoff/wc500048385_en.pdfZeffix : EPAR - Steps taken after authorisation when a cutoff date has been usedhttps://www.ema.europa.eu/system/files/documents/steps-after-cutoff/wc500048385_en.pdfMon, 07 Aug 2006 02:09:21 +0200Human medicine